A nationwide study of primary biliary cholangitis prevalence, geographic distribution, and health care providers
This is the most comprehensive and contemporary estimation of PBC prevalence in the United States to date. The pockets of high prevalence of PBC located in some rural areas highlight the need to better evaluate PBC risk factors and potential barriers in access to specialist care once patients are diagnosed. Greater awareness of PBC and its management are needed.
Authors
- Keri-Ann Buchanan-Peart
- Leona Bessonova (ORCID: https://orcid.org/0000-0002-3893-7910)
- Joanna P. MacEwan (ORCID: https://orcid.org/0000-0003-2702-1170)
- Aparna Goel (ORCID: https://orcid.org/0000-0001-9588-9364)
- Robert G. Gish (ORCID: https://orcid.org/0000-0001-6306-3189)
- Alina Levine
- Cynthia Levy (ORCID: https://orcid.org/0000-0001-5498-6037)
- Alan Bonder (ORCID: https://orcid.org/0000-0001-6821-0416)
- Darren Wheeler
- Radhika Nair (ORCID: https://orcid.org/0000-0003-1404-4496)
Institutions
- Beth Israel Deaconess Medical Center (US)
- Harvard University (US)
- University of Miami (US)
- Intercept Pharmaceuticals (United States) (US)
- Stanford University (US)
Publication Details
- Journal
- Hepatology Communications
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1097/hc9.0000000000000677
- Citations
- 9
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 11.90